Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Juan Luis Steegmann"'
Autor:
Valentín Garcia-Gutiérrez, Alejandro Luna, Juan M. Alonso-Dominguez, Natalia Estrada, Concepcion Boque, Blanca Xicoy, Pilar Giraldo, Anna Angona, Alberto Alvarez-Larrán, Fermin Sanchez-Guijo, María José Ramírez, Elvira Mora, Patricia Vélez, Ana Rosell, Mercedes Colorado Araujo, Beatriz Cuevas, Miguel Sagüés, Montserrat Cortes, Manuel Perez Encinas, Luis Felipe Casado Montero, Melania Moreno Vega, Luis Serrano, Valle Gomez, Carmen Garcia-Hernandez, Sunil Lakhwani, Antonio Paz Coll, Raquel de Paz, Sara Suarez-Varela, Andrés Fernandez-Ruiz, Raul Perez Lopez, Almudena Ortiz-Fernández, Antonio Jiménez-Velasco, Juan Luis Steegmann-Olmedillas, Juan Carlos Hernández-Boluda
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/717b8583ea22422db39b5f3e0735ac0c
Autor:
Lorena Vigón, Sara Rodríguez-Mora, Elena Mateos, Valentín García, Juan Ambrosioni, Nuria Climent, Guiomar Bautista, José Alcamí, Juan Luis Steegmann, Montserrat Plana, José M. Miró, Vicente Planelles, María Rosa López Huertas, Mayte Coiras
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss , Pp 53- (2019)
Externí odkaz:
https://doaj.org/article/87afa0e299bc4dc2a08967af5f2f9447
Autor:
Beatriz Colom-Fernández, Anna Kreutzman, Ana Marcos-Jiménez, Valentín García-Gutiérrez, Carlos Cuesta-Mateos, Itxaso Portero-Sainz, Yaiza Pérez-García, Luis Felipe Casado, Fermín Sánchez-Guijo, Joaquín Martínez-López, Rosa M. Ayala, Concha Boqué, Blanca Xicoy, Isabel Montero, César Soto, Raquel Paz, Gabriela Silva, Lorena Vega-Piris, Juan Luis Steegmann, Cecilia Muñoz-Calleja
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Introduction: Dasatinib is a dual SRC/ABL tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) that is known to have unique immunomodulatory effects. In particular, dasatinib intake typically causes lymphocytosis, which has been lin
Externí odkaz:
https://doaj.org/article/8076d19c9d6e4febaa5ad4e8c9a321dd
Autor:
Lorena Vigón, Alejandro Luna, Miguel Galán, Sara Rodríguez-Mora, Daniel Fuertes, Elena Mateos, Miguel Piris-Villaespesa, Guiomar Bautista, Esther San José, José Rivera-Torres, Juan Luis Steegmann, Fernando de Ory, Mayte Pérez-Olmeda, José Alcamí, Vicente Planelles, María Rosa López-Huertas, Valentín García-Gutiérrez, Mayte Coiras
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 1, p 42 (2020)
BCR-ABL is an aberrant tyrosine kinase responsible for chronic myeloid leukemia (CML). Tyrosine kinase inhibitors (TKIs) induce a potent antileukemic response mostly based on the inhibition of BCR-ABL, but they also increase the activity of Natural K
Externí odkaz:
https://doaj.org/article/c1320c86f7ca4afdb7c0e1178b2df8c3
Autor:
Alberto Alvarez-Larrán, Manuel Pérez-Encinas, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, María José Ramírez, Joaquín Martínez-López, Elena Magro, Yasmina Cruz, María Isabel Mata, Pilar Aragües, María Laura Fox, Beatriz Cuevas, Sara Montesdeoca, José Angel Hernández-Rivas, Valentín García-Gutiérrez, María Teresa Gómez-Casares, Juan Luis Steegmann, María Antonia Durán, Montse Gómez, Ana Kerguelen, Abelardo Bárez, Mari Carmen García, Concepción Boqué, José María Raya, Clara Martínez, Manuel Albors, Francesc García, Carmen Burgaleta, Carlos Besses
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
Hematocrit control below 45% is associated with a lower rate of thrombosis in polycythemia vera. In patients receiving hydroxyurea, this target can be achieved with hydroxyurea alone or with the combination of hydroxyurea plus phlebotomies. However,
Externí odkaz:
https://doaj.org/article/9eb75ba589094b6483910be7f4aa9f39
Autor:
Juan M Alonso-Dominguez, Luis Felipe Casado, Eduardo Anguita, Maria Teresa Gomez-Casares, Ismael Buño, Francisca Ferrer-Marín, Alicia Arenas, Rafael Del Orbe, Rosa Ayala, Pilar Llamas, Rocio N Salgado, Santiago Osorio, Pedro Sanchez-Godoy, Carmen Burgaleta, Ignacio Mahíllo-Fernández, Valentin Garcia-Gutierrez, Juan Luis Steegmann, Joaquín Martinez-Lopez
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181366 (2017)
Patched homolog 1 gene (PTCH1) expression and the ratio of PTCH1 to Smoothened (SMO) expression have been proposed as prognostic markers of the response of chronic myeloid leukemia (CML) patients to imatinib. We compared these measurements in a reali
Externí odkaz:
https://doaj.org/article/5328cd3559c143739de7b645c83762d2
Autor:
Álvaro Cuesta-Domínguez, Mara Ortega, Cristina Ormazábal, Matilde Santos-Roncero, Marta Galán-Díez, Juan Luis Steegmann, Ángela Figuera, Eva Arranz, José Luis Vizmanos, Juan A Bueren, Paula Río, Elena Fernández-Ruiz
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e32451 (2012)
Chromosomal translocations in tumors frequently produce fusion genes coding for chimeric proteins with a key role in oncogenesis. Recent reports described a BCR-JAK2 fusion gene in fatal chronic and acute myeloid leukemia, but the functional behavior
Externí odkaz:
https://doaj.org/article/bc52bc3a930b499690d3aaf99af551e0
Autor:
Lucía Pérez-Lamas, Alejandro Luna, Concepcion Boque, María Alicia Senin, Blanca Xicoy, Pilar Giraldo, Raul Perez Lopez, Concepción Ruiz Nuño, Natalia De las Heras, Elvira Mora Casterá, Carmen Garcia-Hernandez, Adrian Segura Diaz, Juan Luis Steegmann, Patricia Velez Tenza, Fermin Sanchez-Guijo, Ana Maria Garcia-Noblejas Moya, Juan Antonio Juan Vera Goñi, Melania Moreno Vega, Alberto Alvarez-Larran, Montse Cortes, Manuel Perez Encinas, Luis Serrano, Anna Angona, Ana Rosell, Sunil Lakhwani, Mercedes Colorado, Elena Ramila, Carlos Cervero, Beatriz Cuevas, Lucia Villalon Blanco, Juan Carlos Hernandez Boluda, Antonio Paz Coll, Valle Gómez García de Soria, Maria Jose Fernández, Luis Felipe Casado, Juan Manuel Alonso-Dominguez, Maria Magdalena Anguita Arance, Patricia Carrascosa Mastell, Araceli Salamanca Cuenca, Antonio Jiménez-Velasco, María José Ramírez, Miguel López Esteban, Magdalena Sierra Pacho, Marta Santaliestra, Olga Alda Alvarez, Raquel de Paz, Valentín García Gutiérrez
Publikováno v:
Blood. 140:3925-3928
Autor:
Cecilia Muñoz-Calleja, Miguel Vicente-Manzanares, Satu Mustjoki, Juan Luis Steegmann, Alba Juanes-García, Ana de Rosendo, Alvaro Ortega-Carrión, Jani Saarela, Henna Hakanen, Oscar Brück, Cristina Delgado Arévalo, Yaiza Pérez-García, Carlos Cuesta-Mateos, Mette Ilander, Ana Marcos Jiménez, Beatriz Colom-Fernández, Anna Kreutzman
Purpose: Dasatinib is a short-acting dual ABL/SRC family tyrosine kinase inhibitor (TKI), which is frequently used to treat chronic myeloid leukemia. Although very effective, patients taking dasatinib often display severe adverse effects, including p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::159c2f7fec6e8f73254155f053e2465a
https://doi.org/10.1158/1078-0432.c.6526701.v1
https://doi.org/10.1158/1078-0432.c.6526701.v1
Autor:
Cecilia Muñoz-Calleja, Miguel Vicente-Manzanares, Satu Mustjoki, Juan Luis Steegmann, Alba Juanes-García, Ana de Rosendo, Alvaro Ortega-Carrión, Jani Saarela, Henna Hakanen, Oscar Brück, Cristina Delgado Arévalo, Yaiza Pérez-García, Carlos Cuesta-Mateos, Mette Ilander, Ana Marcos Jiménez, Beatriz Colom-Fernández, Anna Kreutzman
Wound healing in control conditions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a20dc83bb9080d4c156bd04dfdc56019
https://doi.org/10.1158/1078-0432.22467636
https://doi.org/10.1158/1078-0432.22467636